|
Title
|
|
|
|
Antimicrobial drug use and macrolide-resistant **Streptococcus pyogenes**, Belgium
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 19972007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 19992009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant S. pyogenes and an increased number of erm(A)-harboring emm77 S. pyogenes with low fitness costs. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Emerging infectious diseases / National Center for Infectious Diseases. Centers for Disease Control and Prevention. - Atlanta, Ga
| |
|
Publication
|
|
|
|
Atlanta, Ga
:
2012
| |
|
ISSN
|
|
|
|
1080-6040
1080-6059
| |
|
DOI
|
|
|
|
10.3201/EID1809.120049
| |
|
Volume/pages
|
|
|
|
18
:9
(2012)
, p. 1515-1518
| |
|
ISI
|
|
|
|
000307989700024
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|